IP Library Assignment 047446/0638
Patent Assignment
Reel/Frame 047446/0638

Security Interest

Recorded: 2018-11-07 Pages: 31
Assignor
MEREO BIOPHARMA 2 LIMITED
Executed: 2018-09-28
Assignee
KREOS CAPITAL V (UK) LIMITED
25 OLD BURLINGTON STREET, LONDON, W1S 3AN, UNITED KINGDOM
Covered Properties (4)
Use of an Aromatase Inhibitor for the Treatment of Hypogonadism and Related Diseases
Patent: 9,295,668 →
Application: 14/342,810 →
Publication: US 2014/0309267
Pharmaceutical Compositions Comprising an Aromatse Inhibitors
Patent: 9,370,505 →
Application: 14/342,813 →
Publication: US 2014/0213622
Use of an Aromatase Inhibitor for the Treatment of Hypogonadism and Related Diseases
Patent: 9,750,724 →
Application: 15/050,394 →
Publication: US 2016/0243084
Pharmaceutical Compositions Comprising an Aromatse Inhibitors
Application: 15/167,867 →
Publication: US 2016/0346257
Related Assignments (9)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 3, 2015
From: NOVARTIS AG
To: NOVARTIS PHARMA AG
Reel/Frame 036952/0483 →
Assignment of Assignor's Interest Nov 8, 2017
From: NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.
To: NOVARTIS AG
Reel/Frame 044412/0851 →
Assignment of Assignor's Interest Nov 8, 2017
From: NOVARTIS PHARMA AG
To: NOVARTIS AG
Reel/Frame 044413/0334 →
Assignment of Assignor's Interest Nov 8, 2017
From: TAYLOR, ANN; KLICKSTEIN, LLOYD B
To: NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.
Reel/Frame 044712/0516 →
Assignment of Assignor's Interest Nov 8, 2017
From: THAKUR, JEEWAN
To: NOVARTIS PHARMA AG
Reel/Frame 044772/0459 →
Assignment of Assignor's Interest Nov 8, 2017
From: NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.
To: NOVARTIS AG
Reel/Frame 044772/0464 →
Assignment of Assignor's Interest Nov 8, 2017
From: TAYLOR, ANN; KLICKSTEIN, LLOYD B
To: NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.
Reel/Frame 044712/0798 →
Change of Address May 23, 2018
From: MEREO BIOPHARMA 2 LIMITED
To: MEREO BIOPHARMA 2 LIMITED
Reel/Frame 048103/0795 →
Release of Security Interest Jan 23, 2021
From: KREOS CAPITAL V (UK) LIMITED
To: MEREO BIOPHARMA 2 LIMITED
Reel/Frame 055010/0637 →